why choose us

First received: November 17, 2022

Clinical Trial: Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cutaneous Lupus Erythematosus (CLE)

Study Type: INTERVENTIONAL


Official Title: A Randomized, Blinded, Placebo-Controlled, Phase 2a, Proof-of-Concept Study to Evaluate Efficacy, Safety, and Tolerability of GS-5718 in Participants With Cutaneous Lupus Erythematosus (CLE)

Brief Summary: The goal of this clinical study is to test how edecesertib (formerly known as GS-5718) can be useful in treating Cutaneous Lupus Erythematosus (CLE) in participants with CLE.Information on what is happening in the body relating to CLE, how the body processes, is affected by and responds to the study drug, and any study drug side effects will also be collected in this study.

Read more